Armata Pharmaceuticals, Inc. (ARMP)
ARMP Stock Price Chart
Explore Armata Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ARMP price movements and trends.
ARMP Company Profile
Discover essential business fundamentals and corporate details for Armata Pharmaceuticals, Inc. (ARMP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 May 1994
Employees
60.00
Website
https://www.armatapharma.comCEO
Deborah L. Birx
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
ARMP Financial Timeline
Browse a chronological timeline of Armata Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.42.
Earnings released on 12 Aug 2025
EPS came in at -$0.32 surpassing the estimated -$0.39 by +17.95%, while revenue for the quarter reached $2.17M , beating expectations by +57.17%.
Earnings released on 14 May 2025
EPS came in at -$0.20 surpassing the estimated -$0.38 by +47.37%, while revenue for the quarter reached $491.00K , missing expectations by -64.42%.
Earnings released on 20 Mar 2025
EPS came in at -$0.23 surpassing the estimated -$0.35 by +34.29%, while revenue for the quarter reached $1.24M , missing expectations by -20.83%.
Earnings released on 13 Nov 2024
EPS came in at -$0.15 surpassing the estimated -$0.28 by +46.43%, while revenue for the quarter reached $2.97M , beating expectations by +90.58%.
Earnings released on 13 Aug 2024
EPS came in at -$0.65 falling short of the estimated -$0.52 by -25.00%.
Earnings released on 7 May 2024
EPS came in at -$0.69 falling short of the estimated -$0.28 by -146.43%, while revenue for the quarter reached $966.00K , missing expectations by -16.00%.
Earnings released on 21 Mar 2024
EPS came in at -$0.55 falling short of the estimated -$0.35 by -57.14%, while revenue for the quarter reached $1.53M , beating expectations by +77.67%.
Earnings released on 14 Nov 2023
EPS came in at -$0.31 surpassing the estimated -$0.33 by +6.06%, while revenue for the quarter reached $1.23M , beating expectations by +42.44%.
Earnings released on 14 Aug 2023
EPS came in at -$0.28 surpassing the estimated -$0.35 by +20.00%, while revenue for the quarter reached $980.00K , missing expectations by -45.86%.
Earnings released on 11 May 2023
EPS came in at -$0.40 falling short of the estimated -$0.29 by -37.93%, while revenue for the quarter reached $796.00K , missing expectations by -55.28%.
Earnings released on 16 Mar 2023
EPS came in at -$0.29 falling short of the estimated -$0.25 by -16.00%, while revenue for the quarter reached $1.05M , missing expectations by -37.07%.
Earnings released on 9 Nov 2022
EPS came in at -$0.24 surpassing the estimated -$0.27 by +11.11%, while revenue for the quarter reached $1.34M , missing expectations by -18.41%.
Earnings released on 11 Aug 2022
EPS came in at -$0.26 matching the estimated -$0.26, while revenue for the quarter reached $1.88M , beating expectations by +67.38%.
Earnings released on 12 May 2022
EPS came in at -$0.30 falling short of the estimated -$0.20 by -50.00%, while revenue for the quarter reached $1.24M , beating expectations by +26.77%.
Earnings released on 17 Mar 2022
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%, while revenue for the quarter reached $2.14K , missing expectations by -99.72%.
Earnings released on 10 Nov 2021
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%.
Earnings released on 12 Aug 2021
EPS came in at -$0.25 matching the estimated -$0.25, while revenue for the quarter reached $1.17M , meeting expectations.
Earnings released on 13 May 2021
EPS came in at -$0.27 surpassing the estimated -$0.28 by +3.57%, while revenue for the quarter reached $1.07M .
Earnings released on 18 Mar 2021
EPS came in at -$0.36 , while revenue for the quarter reached -$31.00K .
Earnings released on 12 Nov 2020
EPS came in at -$0.31 falling short of the estimated -$0.17 by -82.35%, while revenue for the quarter reached $288.00K , beating expectations by +41.18%.
ARMP Stock Performance
Access detailed ARMP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.